Published • loading... • Updated
Lotte Biologics Unveils Next-Generation CDMO Model with Asimov… 8.5 Months From DNA to GMP
Summary by 조선일보
1 Articles
1 Articles
Lotte Biologics has partnered with ASIMOV, a U.S. AI-based cell line development company, to unveil a next-generation biopharmaceutical development and production model. The two companies emphasized their competitiveness in next-generation Contract Development and Manufacturing Organization (CDMO) services by introducing a case study in which they completed the entire process—from DNA development to GMP-compliant active pharmaceutical ingredient…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right1Center0Last UpdatedBias Distribution100% Right
Bias Distribution
- 100% of the sources lean Right
100% Right
R 100%
Factuality
To view factuality data please Upgrade to Premium
